Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
Titel:
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
Auteur:
Papp, Kim Warren, Richard B Green, Lawrence Reich, Kristian Langley, Richard G Paul, Carle Asahina, Akihiko Johnson, Lynne Arora, Vipin Osuntokun, Olawale Lebwohl, Mark